Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Inovio Biomedical Corp (INO)  
$0.58 0.00 (0.00%) as of 4:30 Wed 1/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 169,410,000
Market Cap: 97.83(M)
Last Volume: 3,856,623 Avg Vol: 3,845,860
52 Week Range: $0.35 - $0.885
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 5,700 49,676
Total Sell Value $0 $0 $3,192 $85,601
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 1 7
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 488
  Page 5 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zoth Lota S Director   –       •      –    2021-05-14 4 OE $0.00 $0 D/D 8,700 23,932     -
   Weiner David B. Director   –       •      –    2021-04-21 4 AS $8.54 $227,694 D/D (26,583) 851,136 -6%     
   Weiner David B. Director   –       •      –    2021-04-21 4 OE $2.40 $54,000 D/D 22,500 877,719     -
   Kies Peter CFO   •       –      –    2021-04-21 4 AS $8.52 $85,200 D/D (10,000) 160,788 -6%     
   Benito Simon X Director   –       •      –    2021-04-16 4 AS $8.75 $17,500 D/D (2,000) 51,650 -3%     
   Benito Simon X Director   –       •      –    2021-04-16 4 OE $3.56 $7,120 D/D 2,000 53,650     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-26 4 AS $8.97 $42,249 D/D (4,710) 60,127 2%     
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-25 4 D $9.06 $65,658 D/D (7,247) 64,837     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-25 4 OE $0.00 $0 D/D 16,667 72,084     -
   Miller Ann Calby Director   –       •      –    2021-03-21 4 OE $0.00 $0 D/D 4,274 16,561     -
   Benito Simon X Director   –       •      –    2021-03-16 4 AS $10.41 $20,820 D/D (2,000) 51,650 -21%     
   Benito Simon X Director   –       •      –    2021-03-16 4 OE $3.56 $7,120 D/D 2,000 53,650     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-12 4 AS $10.06 $169,823 D/D (16,881) 55,417 -18%     
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-11 4 D $10.57 $787,941 D/D (74,545) 1,228,658     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-11 4 OE $0.00 $0 D/D 139,387 1,303,203     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-11 4 D $10.57 $274,545 D/D (25,974) 72,298     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-03-11 4 OE $0.00 $0 D/D 59,737 98,272     -
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-11 4 D $10.57 $274,471 D/D (25,967) 89,222     -
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-11 4 OE $0.00 $0 D/D 59,737 115,189     -
   Weiner David B. Director   –       •      –    2021-03-11 4 OE $0.00 $0 D/D 11,667 855,219     -
   Kies Peter CFO   •       –      –    2021-03-11 4 D $10.57 $332,004 D/D (31,410) 170,788     -
   Kies Peter CFO   •       –      –    2021-03-11 4 OE $0.00 $0 D/D 59,737 202,198     -
   Weiner David B. Director   –       •      –    2021-03-09 4 AS $9.60 $33,601 D/D (3,500) 843,552 -8%     
   Kies Peter CFO   •       –      –    2021-03-08 4 D $8.91 $100,576 D/D (11,288) 142,461     -
   Kies Peter CFO   •       –      –    2021-03-08 4 OE $0.00 $0 D/D 21,467 153,749     -
  488 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us